evodiamine has been researched along with Astrocytoma, Grade IV in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YC; Chien, CC; Chiu, WT; Liu, KH; Wu, WS | 1 |
| Chen, KC; Chiu, WT; Hou, SY; Hsiao, SH; Kuei, HP; Liu, AJ; Shih, CM; Shih, YL; Wang, SH | 1 |
| Bi, Y; Fan, L; Gao, H; Khan, M; Qazi, JI | 1 |
3 other study(ies) available for evodiamine and Astrocytoma, Grade IV
| Article | Year |
|---|---|
Evodiamine Prevents Glioma Growth, Induces Glioblastoma Cell Apoptosis and Cell Cycle Arrest through JNK Activation.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Survival; Cell Transformation, Neoplastic; Evodia; Glioblastoma; Glioma; Humans; JNK Mitogen-Activated Protein Kinases; Phosphorylation; Quinazolines; Tumor Cells, Cultured | 2017 |
Evodiamine, a plant alkaloid, induces calcium/JNK-mediated autophagy and calcium/mitochondria-mediated apoptosis in human glioblastoma cells.
Topics: Alkaloids; Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Calcium; Cell Line, Tumor; Evodia; Glioblastoma; Humans; MAP Kinase Signaling System; Models, Biological; Quinazolines | 2013 |
Evodiamine sensitizes U87 glioblastoma cells to TRAIL via the death receptor pathway.
Topics: Apoptosis; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Activation; Glioblastoma; Humans; Quinazolines; Receptors, Death Domain; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand | 2015 |